Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2015 2
2016 1
2019 1
2020 1
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Uterine sarcomas--recent progress and future challenges.
Seddon BM, Davda R. Seddon BM, et al. Among authors: davda r. Eur J Radiol. 2011 Apr;78(1):30-40. doi: 10.1016/j.ejrad.2010.12.057. Epub 2011 Jan 17. Eur J Radiol. 2011. PMID: 21247711 Review.
Targets of Wnt/ß-catenin transcription in penile carcinoma.
Arya M, Thrasivoulou C, Henrique R, Millar M, Hamblin R, Davda R, Aare K, Masters JR, Thomson C, Muneer A, Patel HR, Ahmed A. Arya M, et al. Among authors: davda r. PLoS One. 2015 Apr 22;10(4):e0124395. doi: 10.1371/journal.pone.0124395. eCollection 2015. PLoS One. 2015. PMID: 25901368 Free PMC article.
Advances in advanced prostate cancer - the continuing journey.
Payne H, Davda R, Jones R, Crabb S, Troup J, Hughes S. Payne H, et al. Among authors: davda r. BJU Int. 2016 Jul;118(1):17-9. doi: 10.1111/bju.13350. Epub 2015 Nov 4. BJU Int. 2016. PMID: 26456636 No abstract available.
A Phase II, Open-label study to assess safety and management change using 68Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
Afaq A, Payne H, Davda R, Hines J, Cook GJR, Meagher M, Priftakis D, Warbey VS, Kelkar A, Orczyk C, Mitra A, Needleman S, Ferris M, Mullen G, Bomanji J. Afaq A, et al. Among authors: davda r. J Nucl Med. 2021 Mar 19;62(12):1727-34. doi: 10.2967/jnumed.120.257527. Online ahead of print. J Nucl Med. 2021. PMID: 33741648 Free PMC article.
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial.
Tremblay S, Alhogbani M, Weickhardt A, Davis ID, Scott AM, Hicks RJ, Metser U, Chua S, Davda R, Punwani S, Payne H, Tunariu N, Ho B, Young S, Singbo MNU, Bauman G, Emmett L, Pouliot F. Tremblay S, et al. Among authors: davda r. Cancer Imaging. 2023 Jun 8;23(1):57. doi: 10.1186/s40644-023-00570-x. Cancer Imaging. 2023. PMID: 37291656 Free PMC article.
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
Adeleke S, Latifoltojar A, Sidhu H, Galazi M, Shah TT, Clemente J, Davda R, Payne HA, Chouhan MD, Lioumi M, Chua S, Freeman A, Rodriguez-Justo M, Coolen A, Vadgama S, Morris S, Cook GJ, Bomanji J, Arya M, Chowdhury S, Wan S, Haroon A, Ng T, Ahmed HU, Punwani S. Adeleke S, et al. Among authors: davda r. BMC Med Imaging. 2019 Nov 15;19(1):90. doi: 10.1186/s12880-019-0380-y. BMC Med Imaging. 2019. PMID: 31730466 Free PMC article. Clinical Trial.